Rise of the World'S First Convertible Crypto Bond - The Name Is Bond, Comm'S Bond

SINGAPORE, Feb 26, 2020 - (ACN Newswire) - Crypto Commonwealth has designed a decentralized novel financial product to facilitate sales of its natural token, COMM. "In essence it is a substitute for our main token COMM in lock with the same tokenomics," said Wayne Yee, the founder of Crypto Commonwealth and the leading designer of CBND. "We'd like to give our investors more freedom, offer the market more liquidity and make the locked token sale a trusted and transparent process. We pondered a lot on a derivative product that bears a name of options or futures, but now it's official - the name is Bond, COMM's Bond!"




Initial Coin Offering, or ICO, has emerged as a popular option for fundraising, especially among blockchain-based projects. During an ICO event, the project distributes tokens to the public worldwide, and raises initial funds to grow its digital ecosystem, promote the token use and consolidate its circulation. Typical IPOs and ICOs often come with lock periods, during which the shares or tokens distributed are not tradable. This secures the funds for project development, yet reduces the investment liquidity and strongly restricts the ways investors manage their risks.

A bridge between initial funding and listing, CBND or 'C Bond' is the world's first Convertible Crypto Bond aiming for a solution to this dilemma. It shares certain features in common with convertible bond in the traditional financial market, but with significant simplifications. It is expected to improve COMM's liquidity and locking transparency for its ICO. The token sale is essentially on the crypto underlying, COMM. Unlike typical ICOs, investors would receive tradable CBNDs while having the same amount of COMMs locked. When the lock period is over, 1:1 and one-way redemption would be offered to convert each CBND to COMM, the main token. All redeemed CBNDs would be burnt immediately, leaving the token in scarcity. The remaining and circulating CBNDs in the market, if any, would share the same tokenomics with COMM and continue to persist.

The sales of CBND are conducted at COMM's dedicated ICO website, cryptocommonwealth.co, starting on March 1st, 2020 and to last a month. The CBNDs will be listed immediately after all stages. Meanwhile, sales will run in sync on crypto exchanges of note. COMM has a fixed total supply, 50% of which is reserved for investors in tiered sales, and 30% for ecosystem development and content mining. The remaining 20% is reserved for the team, locked irrevocably by an audited smart contract and to be released linearly over the next 5 years.

A pioneer in scientific publishing and asset management on blockchain, CBND and COMM's issuer, Crypto Commonwealth are committed to building an ecosystem that endows value upon exploration of new knowledge, and promotes it into productivity. It harnesses the power of knowledge produced by leading scholars, and compensates them with fair token payments. This enables crowd based publisher operations and the offering of transparent, research-based investment strategies. Some strategies have already been brought online with capital allocated. Both scientific publishing and asset management industries are highly centralized, globalized and homogeneous among different regions, where decentralized tokenomics and blockchain technology can play an important role, with the assistance of a just currency policy and a well-designed economic model. Crypto Commonwealth believes that a strong crypto project should be open-minded and willing to benefit the welfare of society. That spirit is the best nourishment for the ecosystem under a healthy token distribution structure, where the team and the community's interests fully align. They are hereby forging a crypto ecosystem for the common good, hence the name "Commonwealth".

The CBND and COMM team has a strong background in traditional and digital assets, derivative pricing, and portfolio management. Most of the core team members are quantitative Ph.D.s from renowned tech companies, hedge funds and academic institutions including Google, Cadence, Worldquant, Harvard, MIT, and Fermilab. Moreover, several top advisors are dedicated to assisting their publishing and financing endeavors. Among them are doctoral supervisor in top university, senior derivative quant in investment banking, and #1 ranked experts on reputed ICO rating sites including ICO Bench and ICO Holder.

"The design of CBND was challenging and exciting," said Wayne. "It desired a new pricing mechanism that no one ever thought of before. We started totally from scratch, and were super careful on each feature design. When we eventually came up with this new type of token derivative, we kept going and polished it further to a simple and elegant product, one that adds significant value to its holders. That is, our investors can enjoy much higher liquidity throughout the investment period, and more flexibility in their risk management. The rise of CBND embodies great efforts and expertise of our dedicated team, and we are all very proud of it!"

Whitepaper: https://cryptosmartbeta.com/wp-content/uploads/docs/whitepaper_en.pdf
Twitter: https://twitter.com/CryptoSmartBeta
Facebook: https://www.facebook.com/Crypto-Commonwealth-102262581218579/
Telegram: https://t.me/Crypto_Commonwealth_Europe
Telegram channel: https://t.me/CryptoCommonwealth_ANN
LinkedIn: https://www.linkedin.com/company/cryptocommonwealth
Youtube: https://bit.ly/2wHQAU5

Crypto Commonwealth:
Katula Lamperouge
Inquiries: info@cryptocommonwealth.io
ICO site: cryptocommonwealth.co
Main site: cryptocommonwealth.io


Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57486/

Oxford Medical Case shows Chiropractics can ease Dizziness and Neck Pain

HONG KONG, Feb 26, 2020 - (ACN Newswire) - Just 4 weeks of chiropractic adjustment stimulating proprioception helps people deal with physical pain and annoying dizziness, according to a new case report at Oxford Medical Case Reports.




Neck muscles have numerous interactions with balance and visual centers. Neck problems can alter orientation in space and cause a disturbance of equilibrium. Cervicogenic dizziness is the dizziness associated neck pain and cervical disorders.

A 24-year-old office worker suffered from intermittent neck pain and dizziness for 2 years. She sought help at New York Medical Group and experienced dizziness by moving her head in different motion. All her blood tests, X-rays and MRI could not confirm her symptoms and medication only provided partial relief.

"Cervicogenic dizziness is a seemingly simple complaint for many working adults, but it can be a controversial diagnosis because there are no specific tests for doctors to use," says corresponding author Eric Chun-Pu Chu, chairman of Chiropractic Doctors Association of Hong Kong and author of the study.

The sensory inputs from the neck play an important role in head-eye coordination and postural processes. For example, fish do not have necks and their head and trunk move as one unit in one direction without dizziness. But human has a highly developed sensory system to receive signals and move our trunk. Neck proprioception provides the necessary information about head movements relative to the trunk.

Determining the cause of dizziness is crucial to tailoring the most appropriate treatment protocol. Ruling out neurovascular etiologies is equally important before starting the manual therapy to prevent any untoward events in dizziness.

Chiropractic adjustment has been shown to have benefits in treating many conditions such as headaches and numbness. But Chu and colleagues wanted to know whether a patient with cervicogenic dizziness might benefit from correction of neck posture.

Researchers tested the patient with cervical adjustment and thermal ultrasound therapy, with emphasis on restoring mobility to stiff joints and relieving muscle tightness. Restoration of the cervical curvature was demonstrable on cervical radiographs in the 7th month.

The effect of chiropractic adjustment and ultrasound therapy was effective enough, they found, that both pain and dizziness resolved after 4 weeks of treatments. Researchers found significant relationship between cervical pain and lordosis angle of < 20 degrees. After 18 months, the patient remained free of drugs and symptoms.

The stimulation of cervical proprioceptors and normalization of the afferent input were the result of manual therapy, the author noted.

"The resolution of neck pain or dizziness suggests there may be clinical benefits to chiropractic care in cervicogenic dizziness," Chu says.

Source: Chiropractic Doctors Association of Hong Kong
Study: doi.org/10.1093/omcr/omz115
Dr Eric Chun-Pu Chu
Chairman@cda.org.hk
Chiropractic Doctors Association of Hong Kong

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57485/

Fibocom Launches UNISOC 8910DM Powered LTE Cat.1 Module at Embedded World 2020

Nuremberg, Germany, Feb 26, 2020 - (ACN Newswire) - Fibocom (300638, SZSE), a leading provider of cellular embedded wireless module solutions for the Internet of Things (IoT), is set to unveil its LTE Cat.1 module L610 at the 18th edition of Embedded World.


Fibocom at Embedded World 2020: UNISOC 8910DM Powered LTE Cat.1 Module


Fibocom L610, based on UNISOC 8910DM, the world's first LTE Cat.1 bis chipset platform, is an industrial-grade LTE Cat.1 module with maximum speed up to 10Mbps. What makes it more attractive is its high-performance capability compared with its affordability due to UNISOC's good offer. It supports FDD-LTE/TDD-LTE/GSM long-distance communication and WiFi SCAN/Bluetooth short-range wireless transmission. Fibocom L610 has rich interfaces including UART/SPI/I2C/USB. Built-in LBS, Codec, supports TTS, recording, and VoLTE.

With the commercial launch of 5G, major operators are facing the operational challenges of 2G/3G/4G/5G parallel network and concurrent operation of four generations of users. From a long-term planning perspective, the implementation of 2G/3G network shutting down and 4G network migration is already the general trend in the world. Therefore, Fibocom L610 becomes the best migration choice for IoT users to make a smooth transition for their IoT projects in the future, as it meets the requirements of low-power consumption, and can also solve the CDMA/EVDO network re-framing problem.

Compared with NB-IoT and 2G modules, the Cat.1 module has advantages in network coverage, speed, and latency. Fibocom L610 is the ideal solution to accelerate the next trends of large-scale application of the IoT industries that require cost performance, low latency, wide-area coverage, and real-time communication speed. At present, Fibocom L610 series cover the network bands of major operators in Asia, Europe, and Latin America. In the future, it can be deployed in diversified application scenarios such as smart metering, asset tracking, public network intercom, industrial DTU, smart retailing, and shared hardware, etc.

Fibocom is able to provide a complete solution for IoT customers underlined by its strategy of "Module as a Service", which is the cooperation of providing wireless module, PCB design, IoT application terminal, software platform, and connectivity management to support our customers in any stage of industry innovation and digitalization.

About Fibocom Wireless Inc.
Founded in 1999, Fibocom is the first wireless communication module and Internet of Things (IoT) solution provider listed in China (300638, SZSE). Headquartered in Shenzhen, with R&D center in both Shenzhen and Xi'an, Fibocom is globally located in North America, Europe, India, Taiwan, and Hong Kong, serving customers over 100+ countries. www.fibocom.com

Media Contact:
Ellie Yuan
info@fibocom.com
+86 755 26733555

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57482/

ソニー、焦点距離20mm フルサイズ対応の大口径超広角単焦点レンズ『FE 20mm F1.8 G』を発売

TOKYO, Feb 26, 2020 - (JCN Newswire) - ソニーは、35mmフルサイズ対応Alpha(TM) Eマウントレンズとして、焦点距離20mmの大口径超広角単焦点レンズ『FE 20mm F1.8 G』 を発売します。開放絞りF1.8から画面全域で高い解像力を発揮し、Gレンズならではの高い解像力と美しいぼけ描写を小型軽量設計で実現しています。風景、夜景、建築物はもちろん、小型軽量を生かした日常のスナップなど、幅広い被写体やシーンで活用できるレンズです。加えて、レンズのフォーカス駆動部には、ソニー独自の高推力なXD(eXtreme Dynamic)リニアモーターを2基搭載し、高速・高精度・高追従かつ静粛な高性能AFを実現。静止画だけでなく動画撮影にも適しており、撮影者の映像表現の幅を広げます。

その他特長
- 効果的に配置した高度非球面AA(advanced aspherical)レンズ2枚およびED(特殊低分散)ガラス3枚により、色にじみなどの諸収差を抑制し、星空や夜景などの撮影に適した高い点像再現性を実現。
- 最新の光学設計とメカニカル設計による、最大径73.5mm×長さ84.7mm、質量約373gの小型軽量デザイン。
- 最短撮影距離0.19m(0.2倍の最大撮影倍率)の高い近接撮影能力。
- ナノARコーティングを施すことによる、フレアやゴーストを抑制したクリアで抜けの良い描写。
- 9枚羽根の円形絞りや球面収差形状の最適化による、美しいぼけ描写。
- 焦点距離20mmと高性能なAF、小型軽量設計に加えて、フォーカス時もレンズの長さが変わらないインターナルフォーカシング方式により、ジンバルに装着した状態での快適な動画撮影を実現。
- カスタマイズ可能なフォーカスホールドボタン、絞りリング、AF/MFスイッチ、リニア・レスポンスMFなどによる、高い操作性。
- 防塵防滴に配慮した設計※1、レンズ最前面への汚れが付きにくいフッ素コーティング。
- 超広角ながらレンズ先端にフィルター径67mmのNDフィルターや円偏光フィルターの装着が可能で、多彩な映像表現をサポート。
- ソニー製APS-Cセンサー搭載のミラーレス一眼カメラに装着すれば、明るく高い解像力をもつ焦点距離30mm相当(35mm判換算)の大口径広角単焦点レンズとして使用可能。

本リリースの詳細は下記をご参照ください。
https://www.sony.jp/CorporateCruise/Press/202002/20-0226/

概要:ソニー

詳細は www.sony.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

ソニー、2年連続で倫理的と評価された企業に与えられる「2020 World's Most Ethical Companies(世界で最も倫理的な企業)」に選定

TOKYO, Feb 26, 2020 - (JCN Newswire) - ソニー株式会社(以下、ソニー)はこの度、企業倫理の研究と推進を行う米国の専門機関である「Ethisphere Institute(エシスフィア・インスティテュート)」より、2年連続で「2020 World's Most Ethical Companies(世界で最も倫理的な企業)」に選定されました。

「World's Most Ethical Companies」は、透明性、誠実さ、倫理、コンプライアンスに関する優れた成果を挙げる企業を表彰する賞です。1.企業倫理とコンプライアンスに関する取り組み、2.企業市民としての責任ある行動、3.倫理的企業文化、4.ガバナンス、5.リーダーシップ・外部評価、の5つの項目に基づいて評価が行なわれ、優れた企業として、今年度は世界21か国、132社が選定されました。

ソニーは、「ソニーグループ行動規範」において、「公正である」「誠実である」「正直である」「尊重する」「責任を持つ」といった倫理的行動の核となる指針を定め、この指針を忠実に守りながらイノベーションを生み出していくことを、ソニーグループ全体の方針としています。この方針に基づき、持続的な社会価値の創出に向け、お客様や社員、ビジネスパートナー、事業活動を行う地域のコミュニティといったステークホルダーとのエンゲージメントの強化を積極的に推進しています。

今回の選定は、こうした倫理的な企業風土の醸成および、企業倫理・コンプライアンスプログラムの実施をはじめとする、これまで継続してきた倫理的で責任ある行動が評価された結果であると考えています。

ソニーは、誠実で倫理的な企業文化を大切にし、より一層の取り組みを行ってまいります。

ソニー株式会社 代表執行役 社長 兼 CEO 吉田 憲一郎のコメント
この度、当社が「2020 World's Most Ethical Companies」に選ばれたことについて、大変光栄に思います。高潔かつ誠実であることは、ソニーらしさを形づくる重要な価値観の一つです。今後も長期視点に基づく持続的な社会価値の創出を目指し、グループ全体での取り組みを徹底してまいります。

Ethisphere Institute ティモシー・アーブリックCEOのコメント
今日、従業員や投資家、その他のステークホルダーは、社会的課題に対してリーダーシップを発揮する企業に最も信頼を置いています。自社の存在意義を踏まえた戦略を持ち、長期的視点に基づいて行動する企業は、優れた業績を挙げるだけでなく、長く存続することができます。ソニーが「2020 World's Most Ethical Companies(世界で最も倫理的な企業)」に選定されたことにお祝い申し上げます。

本リリースの詳細は下記をご参照ください。
https://www.sony.co.jp/SonyInfo/News/Press/202002/20-017/

概要:ソニー

詳細は www.sony.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

NEC、POS端末に依存しないPOSソフトウェア「NeoSarf/POS」を提供開始

TOKYO, Feb 26, 2020 - (JCN Newswire) - NECグループは、小売業向けに他社製のPOS端末やPC・Windowsタブレット(注1)にも対応可能なPOSソフトウェア 「NeoSarf/POS」を本年3月から提供開始します。

近年、小売業ではM&Aなどによる事業の拡大が増えてきており、企業内において増加する異なるメーカーのPOS端末を同一のPOSソフトウェアで動作させたいというニーズが高まっています。

本POSソフトウェアは、POS端末に依存せずに導入可能なため、企業内に異なるメーカーのPOS端末が存在する場合でも導入が可能です。また、電子マネーやECサイトとの連携など快適で心地よい購買体験を実現する各種オプション機能や、NECグループの現地サポート体制を活用した保守サポートにより、円滑な店舗運営を支援します。

「NeoSarf/POS」の特長

1. POS端末に依存せず導入可能
NEC製だけでなく、他社製のPOS端末やPC・Windowsタブレットなど多様な形態のPOS端末に対応可能です。これにより、M&AなどによりPOS端末が複数メーカー混在する場合でも、POS端末を統一することなく同一のソフトウェアで稼働できるため、コスト抑制と管理業務の効率化を支援します。

2. 操作性に優れたユーザインターフェースを提供
見やすく分かりやすい直観的な操作が可能な画面デザインを実現するとともに、文字・ボタンサイズ・各項目の配置は利用者のニーズに応じて変更が可能(注2)です。優れたユーザインターフェースにより初心者でも操作がしやすいため、教育コストの削減にも寄与します。

3. 豊富なオプション機能を提供
電子マネーや訪日外国人向け免税手続きソリューション「J-TaxFreeシステム」(注3)などに加え、今後はEC・通販統合ソリューション「NeoSarf/DM」(注4)やQR決済をはじめ約30種類の決済サービスに対応するプラットフォーム「マルチサービスゲートウェイ」(注5)との連携を可能とするオプション機能を提供します。これにより、リアル店舗とECサイトのポイントや購入履歴の統合、また、多様化する決済方法等への対応を実現します。さらに、本ソフトウェア導入後のサポートでは、NECグループの現地サポート体制により迅速なサポート対応が可能です。

本リリースの詳細は下記をご参照ください。
https://jpn.nec.com/press/202002/20200226_01.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

NECと南紀白浜エアポート、南紀白浜エリアでの顔認証技術を用いた「IoTおもてなしサービス実証」の期間延長

TOKYO, Feb 26, 2020 - (JCN Newswire) - 日本電気株式会社(注1、以下NEC)と株式会社南紀白浜エアポート(注2)は、2019年1月から様々な参加施設とともに推進してきた南紀白浜エリアでの顔認証技術を活用した「IoTおもてなしサービス実証」(注3)について、対象施設をさらに追加し、2021年3月31日まで期間を延長します。

本実証では、NECの生体認証「Bio-IDiom」(注4)の中核技術であり、世界No.1(注5)の認証精度を誇る顔認証技術を用いており、生体認証データを一つの共通IDとして利用して安全で快適な旅行体験を実現する環境を提供しています。今回、実証参加施設を12か所まで拡大し、新たにスマートフォン向けアプリ「南紀白浜IoTおもてなしマップ」も提供します。アプリを利用することで、顔情報の登録以外にも、観光情報やイベント情報、バスの時刻表の検索などのサービスが利用可能となります。

本実証は2020年3月13日(金)まで、内閣府の「戦略的イノベーション創造プログラム(SIP)第2期/ビッグデータ・AIを活用したサイバー空間基盤技術/パーソナルデータ実証研究/生体認証(顔特徴量)データの事業者間連携に関するアーキテクチャ実証研究」において、国立研究開発法人 新エネルギー・産業技術総合開発機構(NEDO) の採択を受けて実施しており、今回の延長は、これらの実績・ノウハウなどの研究成果(注6)を受けて、南紀白浜エリアで生体認証データの更なる安全・安心な活用および社会実装を目指します。

なお、従来より本実証にご参加頂いているお客様に対して、実証の延長によるプライバシーポリシーの改訂に関してご案内しています。再同意した方のみ期間延長後のサービスをご利用頂けます。また、再同意のない方の登録データは、2020年2月29日以降速やかに削除します。

NECは、顔や指紋を使った生体認証による共通のIDで、複数の場所やサービスにおいてお客様へ一貫した体験を提供するコンセプト「NEC I:Delight(アイディライト)(注7)」を掲げています。本実証を通じて、観光客やビジネス客の利便性を向上させ、南紀白浜エリアでのおもてなしサービスによる地域経済の発展を支援します。

本実証の内容
初めに、自宅などからスマートフォンを用いて、専用アプリ「南紀白浜IoTおもてなしマップ」や南紀白浜空港の到着階にあるQRコードから、顔情報とクレジットカード情報などを登録します。登録完了後は、ホテルや商業施設、テーマパーク、観光名所などに設置されたカメラから顔情報を検出し、登録された個人を特定することで、各種出迎え業務や、ホテルの客室の解錠、テーマパークでのファスト入園やチケット購入時の決済、さらに商業施設でのショッピングや飲食店利用時の決済などが自動で行えるなど、利便性を高めることによる観光客の満足度向上を目指します。

また、マーケティング分析(「属性推定実験(性別/年齢層)」や「移動経路分析実験」)も実施し、各施設での効果的なキャンペーンやデジタルサイネージ広告に利用します。なお、実証期間中は、おもてなし機能や安全・保安機能を順次強化する予定です。

本リリースの詳細は下記をご参照ください。
https://jpn.nec.com/press/202002/20200226_02.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Food Empire's FY2019 net profit jumps 44.9% to a record US$25.7 million

SINGAPORE, Feb 26, 2020 - (JCN Newswire) - Food Empire Holdings Limited ("Food Empire", together with its subsidiaries, the "Group"), announced today its financial results for the financial year ended 31 December 2019 ("FY2019").

Financial Highlights
https://bit.ly/3c68AYk

Revenue by Markets
https://bit.ly/2uvEXic

Revenue for FY2019 was US$288.6 million, a yoy increase of 1.5% as compared to US$284.3 million revenue recorded in FY2018. This was mainly due to higher sales in local currency terms in the Group's key markets partly offset by lower sales contribution from the Group's South-East Asia market mainly due to rationalisation of underperforming markets and lower translated revenue resulting from depreciation of the Russian Ruble against the US dollar.

Gross profit was US$111.8 million, up 0.8% as compared to prior corresponding period, with gross profit margin of 38.7%.

Selling and marketing expenses were lower by US$6.3 million or 13.3% from US$47.8 million in FY2018 to US$41.5 million. The decrease was mainly due to rationalisation of underperforming markets partly offset by higher manpower cost.

General and administrative expenses decreased by US$1.5 million, from US$41.4 million in FY2018 to US$39.9 million. The decrease was mainly attributable to lower provision for doubtful debts partly offset by higher manpower cost.

Pursuant to the above, the Group's net profit after tax for FY2019 was US$25.7 million, a yoy increase of 44.9%. Net profit margin was 2.7 percentage points ("pp") higher, at 8.9% for FY2019.

For FY2019, the Group generated net operating cash flows of US$39.3 million mainly due to better performance and better working capital management, bringing its cash and cash equivalents to US$54.7 million.

The Board of Directors proposed a first and final dividend of 1 Singapore cent per ordinary share and a special dividend of 1 Singapore cent per ordinary share. The proposed first and final dividend and special dividend are subject to shareholders' approval at the forthcoming Annual General Meeting scheduled for 23 April 2020. If approved, the first and final dividend and special dividend will be paid on 19 May 2020.

Commenting on the Group's results, Mr. Tan Wang Cheow, Executive Chairman of Food Empire said, "FY2019 was a spectacular year for the Group and we are pleased to deliver yet another set of stellar results. The favorable outcome is a testament to the effectiveness of the Group's strategies implemented to address identified problems and improve profitability. Moving ahead, we will remain focused on growing our key markets, streamlining our business operations and looking for strategic mergers & acquisitions opportunities to achieve sustainable growth."

Outlook

The outbreak of the novel coronavirus (COVID-19) in China has since spread to a number of other countries. While efforts have been made to limit the advance of the disease, there is still substantial uncertainty over the duration and severity of COVID-19, which is expected to adversely affect global supply chains and threaten economic growth.

At this moment, the Group assessed that the health crisis is unlikely to have any direct or significant impact on its plans for the year. The Group expects business in its key consumer markets to remain resilient against the backdrop of a moderately acute and well-contained epidemic.

The Group will continue to invest in branding, product development and expanding distribution networks to capture greater consumer mindshare. It will also carry through corporate transformation initiatives to restructure business operations and streamline the organisation into a more cost efficient and sustainable global business.

The Group may face currency volatility in core markets such as Russia, Ukraine, Kazakhstan and CIS countries, which could impact the results of the Group.

Following the success of its first Non-Diary Creamer ("NDC") plant, which is currently fully utilized, the Group has unveiled plans to commence the construction of a second NDC project on its existing plot of land located in the Iskandar region of Malaysia. The project will leverage on existing infrastructures and resources and is expected to take place over the next 24 months. When completed it will increase the existing capacity and offer a wider range of NDC products.

The Group's Instant Freeze Dry Coffee plant in India is expected to be completed and will commence commercial production during the year.

The Group will take a cautious and targeted approach in evaluating M&A opportunities that are synergistic to the Group.

About Food Empire Holdings Limited (Bloomberg Code: FEH SP)

SGX Mainboard-listed Food Empire Holdings (Food Empire) is a global branding and manufacturing company in the food and beverage sector. Its products include instant beverage products, frozen convenience food, confectionery and snack food.

Food Empire's products are exported to over 50 countries, in markets such as Russia, Ukraine, Kazakhstan, Central Asia, China, Indochina, the Middle East, Mongolia and the US. The Group has 24 offices (representative and liaison) worldwide. The Group operates 7 manufacturing facilities in Malaysia, India, Vietnam, Russia and Ukraine.

Food Empire's products include a wide variety of beverages, such as regular and flavoured coffee mixes and cappuccinos, chocolate drinks and flavoured fruit teas. It also markets instant breakfast cereal, potato crisps and assorted frozen convenience foods.

Food Empire's strength lies in its proprietary brands - including MacCoffee, Petrovskaya Sloboda, Klassno, Hyson, OrienBites and Kracks. MacCoffee - the Group's flagship brand - has been consistently ranked as the leading 3-in-1 instant coffee brand in the Group's core market of Russia, Ukraine and Kazakhstan. The Group employs sophisticated brand building activities, localised to match the flavour of the local markets in which its products are sold.

Since its public listing in 2000, Food Empire has won numerous accolades and awards including being recognised as one of the "Most Valuable Singapore Brands" by IE Singapore (now known as Enterprise Singapore), while MacCoffee has been ranked as one of "The Strongest Singapore Brands". Forbes Magazine has twice named Food Empire as one of the "Best under a Billion" companies in Asia and the company has also been awarded one of Asia's "Top Brand" by Influential Brands. For more information, please refer to: http://www.foodempire.com

Issued for and on behalf of Food Empire Holdings Limited.
by Financial PR Pte Ltd
Mr Ngo Yit Sung, yitsung@financialpr.com.sg
Ms Yong Jing Wen, jingwen@financialpr.com.sg
Tel: +65 6438 2990 Fax: +65 6438 0064



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

LEXUS、ミラノデザインウィーク2019へ出展

Toyota City, Japan, Feb 26, 2020 - (JCN Newswire) - LEXUSは、2019年4月8日(月)~14日(日)、イタリア・ミラノで開催される世界最大のデザインイベント、ミラノデザインウィーク2019*1に出展し、世界中のクリエーションが集結するトルトーナ地区(Tortona)の中心であるスーパースタジオ・ピュー内アートポイント(Superstudio Più)において、「LEXUS DESIGN EVENT 2019 – LEADING WITH LIGHT」を開催します。

通算12回目のミラノデザインウィーク出展となる今回は、テクノロジーは人のためにデザインしてこそその価値が生まれるというLEXUSの思想“Human-Centered”(人間中心)デザインを光のメディアアートで表現し、テクノロジーがよりよい未来へと来場者を誘うインスタレーションを展示します。

コラボレーションデザイナーとして参画するアーティスト集団Rhizomatiksは、主にデザイン、アート、エンターテインメントの領域で活動しており、特にテクノロジーをベースに光と音楽による演出で人々を魅了するメディアアート作品で世界中から高い評価を受けています。彼らのクリエーションの根幹にある、常に人を中心(Human-Centered)としたデザインのあり方が、LEXUSの思想と強く共鳴し、今回のコラボレーションが実現しました。

「LEADING WITH LIGHT」は、無数の光線に包まれた空間で、人間の動きに呼応して自由自在に動くロボットが作り出すインスタレーションです。Human-centeredの思想がもたらす光というテクノロジーの限りない可能性を示唆します。

また、会場内では、LEXUS DESIGN AWARD 2019のファイナリスト6名によるプロトタイプ作品を展示します。4月8日(月)のプレスデーでは、ファイナリストたちが作品のプレゼンテーションを行い、グランプリの受賞者が発表されます。イベント詳細に関しては、LEXUS DESIGN EVENTおよびLEXUS DESIGN AWARDの公式サイトで公開されます。

さらに「LEXUS DESIGN EVENT 2019 – LEADING WITH LIGHT」と連動して、未来を創造するテクノロジーカルチャーの祭典「Media Ambition Tokyo 2019」へ参加。株式会社ライゾマティクス 齋藤精一氏、デジタルハリウッド大学学長 杉山知之氏、JTQ代表 谷川じゅんじ氏などの著名なゲストと、Lexus International 須賀厚一(デザイナー)のトークイベントを開催するほか、LEXUSの活動を通じて生まれたアート&テクノロジー作品を展示する予定です。

本リリースの詳細は下記URLをご参照ください。
https://newsroom.toyota.co.jp/jp/lexus/26655976.html

概要:トヨタ自動車株式会社

詳細は http://toyota.jp/ をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

BTS Takes Over Twitter with 17 Million Tweets in 48 Hours

SEOUL, KOREA, Feb 25, 2020 - (Media OutReach) - Global superstars BTS (@BTS_twt) released their highly-anticipated album, "MAP OF THE SOUL : 7" on 21 February, 6pm (KST), and ARMY all over the world naturally took to Twitter to rave all about it. From 21 February 6am to 23 February 6am (KST), 17 Million BTS-related Tweets were generated within 48 hours.


BTS's #MAP_OF_THE_SOUL_7 related Tweet Trandmap


Tweet volumes peaked within the first hour when the album was released, generating 1.2 Million Tweets from 6pm to 7pm (KST) on 21 February. The Top Tweet from BTS (@BTS_twt) official account was 'D-Day', announcing the day of their comeback with a series of photos including a selfie from RM and various artworks.

(Embeddable Tweet: https://twitter.com/BTS_twt/status/1230518011586478080)

Here is a list of Top 5 Tweets from the official BTS members account (@BTS_twt) and BTS' Label, Big Hit Entertainment (@BTS_bighit).

Top 5 Tweets from BTS account
1. https://twitter.com/BTS_twt/status/1230518011586478080
2. https://twitter.com/BTS_twt/status/1230626716428587008
3. https://twitter.com/bts_bighit/status/1230598088647172096
4. https://twitter.com/bts_bighit/status/1230658502982430721
5. https://twitter.com/bts_bighit/status/1230718828205637633

Sia (@sia) and Justin Bieber's (@justinbieber) Tweets related to BTS' new album has also gained a lot of attention.

(Embeddable Tweet: https://twitter.com/Sia/status/1230851415591051264)
(Embeddable Tweet: https://twitter.com/justinbieber/status/1231429797739257856)

With the BTS ARMY going wild on Twitter, the top hashtags excluding #BTS and #* was the album title #MAP_OF_THE_SOUL_7, Next on the list is #BTSComeback2020 and lead single, #ON.

Top hashtags (Excluding #BTS, #* (BTS))
1. #MAP_OF_THE_SOUL_7
2. #BTSComeback2020
3. #ON
4. #Connect_BTS
5. #WeOnWithBTS

Fans all over the world turned to Twitter to join the #MAP_OF_THE_SOUL_7 conversations and #BTS updates. Come and join Twitter conversation today to see and talk about your favourite Kpop idols and stay updated everyday with other Kpop fans around the world!

About Twitter

Twitter, Inc. (NYSE: TWTR) is what's happening in the world and what people are talking about right now. On Twitter, live comes to life as conversations unfold, showing you all sides of the story. From breaking news and entertainment to sports, politics and everyday interests, when things happen in the world, they happen first on Twitter. Twitter is available in more than 40 languages around the world. The service can be accessed at twitter.com, on a variety of mobile devices and via SMS. For more information, visit about.twitter.com or follow @TwitterKorea. For information on how to download the Twitter and Periscope apps, visit twitter.com/download and periscope.tv.

Media Contact
Heejung Shin
Twitter Korea
Email: Heejungs@twitter.com
Twitter: @xinxi1

* Some terms in this release are displayed in Korean as indicated with asterisk. Please refer to the full release at https://www.media-outreach.com/View/28861/


BTS's #MAP_OF_THE_SOUL_7 related Tweet Trandmap



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

三菱商事、株式会社クリスプホールディングスと資本業務提携契約を締結

TOKYO, Feb 25, 2020 - (JCN Newswire) - 三菱商事株式会社(以下、三菱商事)は、株式会社クリスプホールディングス(以下、クリスプHD)が行う第三者割当増資(出資比率:18.4%)を引き受けることを決定し、資本業務提携契約(以下、「本提携」)を締結しました。

クリスプHDは「熱狂的なファンをつくる」をミッションに掲げ、主食としてのサラダを提供するカスタムサラダ専門店「CRISP SALAD WORKS」(国内14店舗)を運営しており、また、「飲食店の顧客体験を進化させる」ことを目的に、自社開発したモバイルオーダー・オンライン決済・店舗運営・CRM*1を一括提供するシステム「PLATFORM」を外食事業者に販売する、SaaS*2事業も手掛けています。

近年、外食産業では、人手不足・食品ロス発生等の構造的課題を解決する為、デジタル技術を活用したシステムの導入が進んでいますが、長期の開発期間、多額の初期投資等の障壁から、事業所数で市場の約8割を占める中小事業者への導入が進んでおりませんでした。クリスプHDは、自社開発した「PLATFORM」をSaaS形式で他外食事業者に販売することで、少額の投資と短いリードタイムでの利用開始を可能としています。

「PLATFORM」は店舗オペレーションの効率化や食品ロスの削減に留まらず、蓄積されるデータに基づく消費者の嗜好や属性に合わせたマーケティングや、Life Time Value*3の向上に資する経営をサポートするシステムです。また、「PLATFORM」に天候等の外部データとAI学習を組入れ、売上予測・自動発注等の機能を付加していく等、オンラインとオフラインが融合した次世代型店舗の開発にも取り組んでいます。

本提携は、「経済価値」「社会価値」「環境価値」の同時実現を目指す三菱商事と、外食産業の社会課題解決を経営方針の軸に据えるクリスプHDの取組みを発展させるものです。三菱商事グループが有する産業知見とネットワークを活用することで、クリスプHDのブランドバリュー向上と経営ビジョンの実現に貢献すると共に、「PLATFORM」を活用した新たな事業モデルの構築等にも取り組んで参ります。また、本提携の円滑な推進の為、常勤取締役1名を三菱商事より派遣する予定です。

尚、本提携は、消費者価値創造と人財育成に資する事業開発の促進を主目的として三菱商事のコンシューマー産業グループが実施している、新規事業公募制度への応募により、具現化された案件です。今後も社員一人ひとりの事業構想と挑戦を後押しし、新たな価値創造を目指して参ります。

本リリースの詳細は下記URLをご参照ください。
https://www.mitsubishicorp.com/jp/ja/pr/archive/2020/html/0000039308.html

概要:三菱商事株式会社

詳細は www.mitsubishicorp.com をご参照ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

BTS Takes Over Twitter with 17 Million Tweets in 48 Hours

SEOUL, KOREA, Feb 25, 2020 - (ACN Newswire) - Global superstars BTS (@BTS_twt) released their highly-anticipated album, "MAP OF THE SOUL : 7" on 21 February, 6pm (KST), and ARMY all over the world naturally took to Twitter to rave all about it. From 21 February 6am to 23 February 6am (KST), 17 Million BTS-related Tweets were generated within 48 hours.


BTS's #MAP_OF_THE_SOUL_7 related Tweet Trandmap


Tweet volumes peaked within the first hour when the album was released, generating 1.2 Million Tweets from 6pm to 7pm (KST) on 21 February. The Top Tweet from BTS (@BTS_twt) official account was 'D-Day', announcing the day of their comeback with a series of photos including a selfie from RM and various artworks.

(Embeddable Tweet: https://twitter.com/BTS_twt/status/1230518011586478080)

Here is a list of Top 5 Tweets from the official BTS members account (@BTS_twt) and BTS' Label, Big Hit Entertainment (@BTS_bighit).

Top 5 Tweets from BTS account
1. https://twitter.com/BTS_twt/status/1230518011586478080
2. https://twitter.com/BTS_twt/status/1230626716428587008
3. https://twitter.com/bts_bighit/status/1230598088647172096
4. https://twitter.com/bts_bighit/status/1230658502982430721
5. https://twitter.com/bts_bighit/status/1230718828205637633

Sia (@sia) and Justin Bieber's (@justinbieber) Tweets related to BTS' new album has also gained a lot of attention.

(Embeddable Tweet: https://twitter.com/Sia/status/1230851415591051264)
(Embeddable Tweet: https://twitter.com/justinbieber/status/1231429797739257856)

With the BTS ARMY going wild on Twitter, the top hashtags excluding #BTS and #* was the album title #MAP_OF_THE_SOUL_7, Next on the list is #BTSComeback2020 and lead single, #ON.

Top hashtags (Excluding #BTS, #* (BTS))
1. #MAP_OF_THE_SOUL_7
2. #BTSComeback2020
3. #ON
4. #Connect_BTS
5. #WeOnWithBTS

Fans all over the world turned to Twitter to join the #MAP_OF_THE_SOUL_7 conversations and #BTS updates. Come and join Twitter conversation today to see and talk about your favourite Kpop idols and stay updated everyday with other Kpop fans around the world!

About Twitter

Twitter, Inc. (NYSE: TWTR) is what's happening in the world and what people are talking about right now. On Twitter, live comes to life as conversations unfold, showing you all sides of the story. From breaking news and entertainment to sports, politics and everyday interests, when things happen in the world, they happen first on Twitter. Twitter is available in more than 40 languages around the world. The service can be accessed at twitter.com, on a variety of mobile devices and via SMS. For more information, visit about.twitter.com or follow @TwitterKorea. For information on how to download the Twitter and Periscope apps, visit twitter.com/download and periscope.tv.

Media Contact
Heejung Shin
Twitter Korea
Email: Heejungs@twitter.com
Twitter: @xinxi1

* Some terms in this release are displayed in Korean as indicated with asterisk. Please refer to the full release at https://www.media-outreach.com/View/28861/

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57472/

COMM's New Project Launch Integrates Publisher and Hedge Funds on Blockchain

SINGAPORE, Feb 25, 2020 - (ACN Newswire) - When people talk about the biggest scientific publishers, the names Nature and Science are always included. The ongoing blockchain revolution is incubating such an excellent publishing house, that brings together different ecosystems and integrates breakthrough technologies. COMM merges into its innovative ecosystem the wisdom of an elite publisher with the profit-making power of a hedge fund, compensating contributors to both branches generously.




As the issuer of COMM the digital currency, Crypto Commonwealth is considered to be a most ambitious blockchain project. Its vision is to create a community that incentivizes effort and quality of publications, with the ultimate goal to create a journal as successful as Nature and Science. The project claims to have a strong network of researchers in top universities, and plans to invite more of them to join, as well as funding their research in academia. They intend to distribute 100% net publishing profit back to the authors, editors and reviewers, paying for their contributions in their native token COMM. Excellent contributions make the ecosystem stronger, encouraging and inviting more people to play a part within as everybody looks for incentives.

The Commonwealth Publisher offers three columns and targets for varied reader groups. The professional column 'Beta for Pros' is expected to cover topics typical financial journals would discuss, including macro and micro dynamics, market inefficiency, behavioral finance, strategy research, risk management and more. COMM also has two more columns intended for generic readers that serve as educational resources and crypto knowledge base, 'Beta for fun' and 'Crypto Insights'. They cover quantitative and fun crypto analysis, tokenomics and philosophies, as well as non-quantitative articles in the blockchain domain including crypto overviews, insights, token mechanism / algorithm, macro visions, blockchain techniques, etc.

The long term vision of the Commonwealth Publisher is to acquire high-quality, stable submissions and a good impact factor, then start charging subscription and publishing fees as any other commercial journals. More importantly, it plans to redistribute all profits after operational costs back to the authors, editors and reviewers. This is a closed cycle that is expected to nourish and sustain the ecosystem as it starts to gain momentum.

Crypto Commonwealth focuses not only on becoming a top tier publisher of all things, crypto or otherwise. It also envisions becoming a digital and traditional asset manager that outperforms BTC and the stock market in the long term. Its strategy construction follows the "trilemma in portfolio management". Under this model three variables are considered: high return, low risk, and high capacity. Those who have some experience investing in traditional or crypto assets, either in IPOs, ICOs, IEOs or directly in the secondary markets have learned, maybe the hard way, that it is not possible to embrace these three vertices simultaneously. For COMM the presence of two of these factors excludes the third as well.

It is on this understanding that high return and low risk exclude high capacity, such as in alphas and high frequency trading. Crypto Commonwealth itself encompasses hedge funds including the alpha fund "Sphinx" and the smart beta fund "Stonybrook" under the high return and low risk classification. It offers detailed, professional suggestions to help investors make the most informed decisions on investment products. Profit will be redistributed into the ecosystem in decent proportion: up to 50% of management or incentive fee would be shared among excellent authors, portfolio managers, researchers and collaborators.

Strategy contributors can opt to be external or internal researchers. Internal researchers are expected to run backtests on the platform and submit alphas for centralized post-processing, including portfolio combination and optimization. However, this is by no means limited thereto. Upon proper evaluation, a certain amount of COMMs will be paid out as a reward, with a significant amount to be followed pending the alpha performance out-of-sample and in live trading. These of course are what could be considered the right steps to build a strong and wise community.

The COMM team has a strong background in global stock and crypto markets, having amassed a good number of lowly correlated strategies at their disposal. The project is seeking to tokenize them as soon as circumstances permit. Those who have been following the cryptocurrency market recognize that tokenization of other financial markets, like commodities, futures, stocks, currencies, bonds and real estate is promised to be even bigger in capitalization than all the current cryptocurrencies. A real pioneer in strategy tokenization, COMM will certainly build a supportive and productive atmosphere for portfolio managers across multiple markets to participate in its ecosystem.

A promising project, Crypto Commonwealth harbors the first scientific publisher and investment institute in house on blockchain. It's well backed by a community of investors, scholars, researchers and engineers. With its global payment network in play, COMM endeavors to redistribute profits fairly among its contributing members and disrupt the traditional model in both fields, benefiting the COMMunity and the public.

Whitepaper: https://cryptosmartbeta.com/wp-content/uploads/docs/whitepaper_en.pdf
Twitter: https://twitter.com/CryptoSmartBeta
Facebook: https://www.facebook.com/Crypto-Commonwealth-102262581218579/
Telegram: https://t.me/Crypto_Commonwealth_Europe
Telegram channel: https://t.me/CryptoCommonwealth_ANN
LinkedIn: https://www.linkedin.com/company/cryptocommonwealth
Youtube: https://bit.ly/2wHQAU5
Instagram: https://www.instagram.com/crypto_smart_beta/

Crypto Commonwealth:
Katula Lamperouge
Inquiries: info@cryptocommonwealth.io
ICO site: cryptocommonwealth.co
Main site: cryptocommonwealth.io


Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57420/

COMM's New Project Launch Integrates Publisher and Hedge Funds on Blockchain

SINGAPORE, Feb 25, 2020 - (JCN Newswire) - When people talk about the biggest scientific publishers, the names Nature and Science are always included. The ongoing blockchain revolution is incubating such an excellent publishing house, that brings together different ecosystems and integrates breakthrough technologies. COMM merges into its innovative ecosystem the wisdom of an elite publisher with the profit-making power of a hedge fund, compensating contributors to both branches generously.

As the issuer of COMM the digital currency, Crypto Commonwealth is considered to be a most ambitious blockchain project. Its vision is to create a community that incentivizes effort and quality of publications, with the ultimate goal to create a journal as successful as Nature and Science. The project claims to have a strong network of researchers in top universities, and plans to invite more of them to join, as well as funding their research in academia. They intend to distribute 100% net publishing profit back to the authors, editors and reviewers, paying for their contributions in their native token COMM. Excellent contributions make the ecosystem stronger, encouraging and inviting more people to play a part within as everybody looks for incentives.

The Commonwealth Publisher offers three columns and targets for varied reader groups. The professional column 'Beta for Pros' is expected to cover topics typical financial journals would discuss, including macro and micro dynamics, market inefficiency, behavioral finance, strategy research, risk management and more. COMM also has two more columns intended for generic readers that serve as educational resources and crypto knowledge base, 'Beta for fun' and 'Crypto Insights'. They cover quantitative and fun crypto analysis, tokenomics and philosophies, as well as non-quantitative articles in the blockchain domain including crypto overviews, insights, token mechanism / algorithm, macro visions, blockchain techniques, etc.

The long term vision of the Commonwealth Publisher is to acquire high-quality, stable submissions and a good impact factor, then start charging subscription and publishing fees as any other commercial journals. More importantly, it plans to redistribute all profits after operational costs back to the authors, editors and reviewers. This is a closed cycle that is expected to nourish and sustain the ecosystem as it starts to gain momentum.

Crypto Commonwealth focuses not only on becoming a top tier publisher of all things, crypto or otherwise. It also envisions becoming a digital and traditional asset manager that outperforms BTC and the stock market in the long term. Its strategy construction follows the "trilemma in portfolio management". Under this model three variables are considered: high return, low risk, and high capacity. Those who have some experience investing in traditional or crypto assets, either in IPOs, ICOs, IEOs or directly in the secondary markets have learned, maybe the hard way, that it is not possible to embrace these three vertices simultaneously. For COMM the presence of two of these factors excludes the third as well.

It is on this understanding that high return and low risk exclude high capacity, such as in alphas and high frequency trading. Crypto Commonwealth itself encompasses hedge funds including the alpha fund "Sphinx" and the smart beta fund "Stonybrook" under the high return and low risk classification. It offers detailed, professional suggestions to help investors make the most informed decisions on investment products. Profit will be redistributed into the ecosystem in decent proportion: up to 50% of management or incentive fee would be shared among excellent authors, portfolio managers, researchers and collaborators.

Strategy contributors can opt to be external or internal researchers. Internal researchers are expected to run backtests on the platform and submit alphas for centralized post-processing, including portfolio combination and optimization. However, this is by no means limited thereto. Upon proper evaluation, a certain amount of COMMs will be paid out as a reward, with a significant amount to be followed pending the alpha performance out-of-sample and in live trading. These of course are what could be considered the right steps to build a strong and wise community.

The COMM team has a strong background in global stock and crypto markets, having amassed a good number of lowly correlated strategies at their disposal. The project is seeking to tokenize them as soon as circumstances permit. Those who have been following the cryptocurrency market recognize that tokenization of other financial markets, like commodities, futures, stocks, currencies, bonds and real estate is promised to be even bigger in capitalization than all the current cryptocurrencies. A real pioneer in strategy tokenization, COMM will certainly build a supportive and productive atmosphere for portfolio managers across multiple markets to participate in its ecosystem.

A promising project, Crypto Commonwealth harbors the first scientific publisher and investment institute in house on blockchain. It?s well backed by a community of investors, scholars, researchers and engineers. With its global payment network in play, COMM endeavors to redistribute profits fairly among its contributing members and disrupt the traditional model in both fields, benefiting the COMMunity and the public.

Whitepaper: https://cryptosmartbeta.com/wp-content/uploads/docs/whitepaper_en.pdf
Twitter: https://twitter.com/CryptoSmartBeta
Facebook: https://www.facebook.com/Crypto-Commonwealth-102262581218579/
Telegram: https://t.me/Crypto_Commonwealth_Europe
Telegram channel: https://t.me/CryptoCommonwealth_ANN
LinkedIn: https://www.linkedin.com/company/cryptocommonwealth
Youtube: https://bit.ly/2wHQAU5
Instagram: https://www.instagram.com/crypto_smart_beta/

Crypto Commonwealth:
Katula Lamperouge
Inquiries: info@cryptocommonwealth.io
ICO site: cryptocommonwealth.co
Main site: cryptocommonwealth.io



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

日立グローバルライフソリューションズ、業務用空調機の室内ユニット「てんかせ4方向」ユーザーにIoTを活用した会議室管理サービス「exiida会議室管理」の提供を開始

TOKYO, Feb 25, 2020 - (JCN Newswire) - 日立グローバルライフソリューションズ株式会社(取締役社長:谷口 潤)は、日立業務用空調機室内ユニット「てんかせ4方向(*1)」とIoTを活用した、「exiida(エクシーダ)(*2)会議室管理」のサービス提供を2020年4月1日から開始します。「てんかせ4方向」ユーザーに、会議室などの予約に加え、在室状況の把握、および予約の残り時間をお知らせする予鈴機能を備えた高機能な「会議室管理」システムを、導入が手軽なサブスクリプション方式で提供します。

開発背景

政府主導で推進している「働き方改革」の取り組みの一つとして、職場の非効率な業務プロセスの見直しが挙げられています。そこで、弊社は会議室の空き室確認や予約など、会議室管理業務の効率化について着目しました。

会議室のほぼ中央の天井面に設置される「てんかせ4方向」の特長を生かし、コーナーパネルに在室を検知する人感センサーと予鈴機能を実装することで、会議室の有効な活用、および会議時間管理のサポートが可能となり、会議室管理業務の効率化を提供していきます。

「exiida会議室管理」の特長

1. 会議室管理用の専用端末が不要
インターネットに接続したWebブラウザで操作するため、専用端末は必要ありません。外出先からでもタブレットやスマートフォンなどのさまざまな端末から、簡単に会議室の予約状況・在室状況の確認、予約操作が行えます。

2. 自動キャンセル、予鈴機能により、使いやすい会議室管理を提供
不在時自動キャンセル機能により、会議室の予約の取り消し忘れなどによる「空予約」の解消を図ります。これにより、利用していない会議室が明確となり、会議室を利用したい使用者の予約を受付けられるなど、会議室が有効に活用できます。また、会議室利用時間に合わせて音や光で予約終了時間をお知らせする予鈴機能により、会議の時間管理をサポートいたします。

3. 会議室の稼働率状況などの分析
会議室の予約率や、その予約に対する稼働率を分析することが可能です。会議室の有効な運用方法や、会議室のレイアウト変更などの計画に反映できます。

4. 会議室内での新たな電源工事は不要
「会議室管理用パネル」の据え付けは、てんかせ4方向のコーナーパネルとの交換と、制御基板への電源接続で完了するため、新たな電源工事は不要です。また、会議室管理用パネル間、およびゲートウェイ間は無線通信を行うため、通信に係る工事も最小限で済みます(*6)。

本リリースの詳細は下記URLをご参照ください。
https://www.hitachi.co.jp/New/cnews/month/2020/02/0225.html

概要:日立製作所

詳細は www.hitachi.co.jp をご参照ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Food Empire's FY2019 net profit jumps 44.9% to a record US$25.7 million

SINGAPORE, Feb 25, 2020 - (ACN Newswire) - Food Empire Holdings Limited ("Food Empire", together with its subsidiaries, the "Group"), announced today its financial results for the financial year ended 31 December 2019 ("FY2019").






Financial Highlights
https://bit.ly/3c68AYk

Revenue by Markets
https://bit.ly/2uvEXic

Revenue for FY2019 was US$288.6 million, a yoy increase of 1.5% as compared to US$284.3 million revenue recorded in FY2018. This was mainly due to higher sales in local currency terms in the Group's key markets partly offset by lower sales contribution from the Group's South-East Asia market mainly due to rationalisation of underperforming markets and lower translated revenue resulting from depreciation of the Russian Ruble against the US dollar.

Gross profit was US$111.8 million, up 0.8% as compared to prior corresponding period, with gross profit margin of 38.7%.

Selling and marketing expenses were lower by US$6.3 million or 13.3% from US$47.8 million in FY2018 to US$41.5 million. The decrease was mainly due to rationalisation of underperforming markets partly offset by higher manpower cost.

General and administrative expenses decreased by US$1.5 million, from US$41.4 million in FY2018 to US$39.9 million. The decrease was mainly attributable to lower provision for doubtful debts partly offset by higher manpower cost.

Pursuant to the above, the Group's net profit after tax for FY2019 was US$25.7 million, a yoy increase of 44.9%. Net profit margin was 2.7 percentage points ("pp") higher, at 8.9% for FY2019.

For FY2019, the Group generated net operating cash flows of US$39.3 million mainly due to better performance and better working capital management, bringing its cash and cash equivalents to US$54.7 million.

The Board of Directors proposed a first and final dividend of 1 Singapore cent per ordinary share and a special dividend of 1 Singapore cent per ordinary share. The proposed first and final dividend and special dividend are subject to shareholders' approval at the forthcoming Annual General Meeting scheduled for 23 April 2020. If approved, the first and final dividend and special dividend will be paid on 19 May 2020.

Commenting on the Group's results, Mr. Tan Wang Cheow, Executive Chairman of Food Empire said, "FY2019 was a spectacular year for the Group and we are pleased to deliver yet another set of stellar results. The favorable outcome is a testament to the effectiveness of the Group's strategies implemented to address identified problems and improve profitability. Moving ahead, we will remain focused on growing our key markets, streamlining our business operations and looking for strategic mergers & acquisitions opportunities to achieve sustainable growth."

Outlook

The outbreak of the novel coronavirus (COVID-19) in China has since spread to a number of other countries. While efforts have been made to limit the advance of the disease, there is still substantial uncertainty over the duration and severity of COVID-19, which is expected to adversely affect global supply chains and threaten economic growth.

At this moment, the Group assessed that the health crisis is unlikely to have any direct or significant impact on its plans for the year. The Group expects business in its key consumer markets to remain resilient against the backdrop of a moderately acute and well-contained epidemic.

The Group will continue to invest in branding, product development and expanding distribution networks to capture greater consumer mindshare. It will also carry through corporate transformation initiatives to restructure business operations and streamline the organisation into a more cost efficient and sustainable global business.

The Group may face currency volatility in core markets such as Russia, Ukraine, Kazakhstan and CIS countries, which could impact the results of the Group.

Following the success of its first Non-Diary Creamer ("NDC") plant, which is currently fully utilized, the Group has unveiled plans to commence the construction of a second NDC project on its existing plot of land located in the Iskandar region of Malaysia. The project will leverage on existing infrastructures and resources and is expected to take place over the next 24 months. When completed it will increase the existing capacity and offer a wider range of NDC products.

The Group's Instant Freeze Dry Coffee plant in India is expected to be completed and will commence commercial production during the year.

The Group will take a cautious and targeted approach in evaluating M&A opportunities that are synergistic to the Group.

About Food Empire Holdings Limited (Bloomberg Code: FEH SP)

SGX Mainboard-listed Food Empire Holdings (Food Empire) is a global branding and manufacturing company in the food and beverage sector. Its products include instant beverage products, frozen convenience food, confectionery and snack food.

Food Empire's products are exported to over 50 countries, in markets such as Russia, Ukraine, Kazakhstan, Central Asia, China, Indochina, the Middle East, Mongolia and the US. The Group has 24 offices (representative and liaison) worldwide. The Group operates 7 manufacturing facilities in Malaysia, India, Vietnam, Russia and Ukraine.

Food Empire's products include a wide variety of beverages, such as regular and flavoured coffee mixes and cappuccinos, chocolate drinks and flavoured fruit teas. It also markets instant breakfast cereal, potato crisps and assorted frozen convenience foods.

Food Empire's strength lies in its proprietary brands - including MacCoffee, Petrovskaya Sloboda, Klassno, Hyson, OrienBites and Kracks. MacCoffee - the Group's flagship brand - has been consistently ranked as the leading 3-in-1 instant coffee brand in the Group's core market of Russia, Ukraine and Kazakhstan. The Group employs sophisticated brand building activities, localised to match the flavour of the local markets in which its products are sold.

Since its public listing in 2000, Food Empire has won numerous accolades and awards including being recognised as one of the "Most Valuable Singapore Brands" by IE Singapore (now known as Enterprise Singapore), while MacCoffee has been ranked as one of "The Strongest Singapore Brands". Forbes Magazine has twice named Food Empire as one of the "Best under a Billion" companies in Asia and the company has also been awarded one of Asia's "Top Brand" by Influential Brands. For more information, please refer to: http://www.foodempire.com

Issued for and on behalf of Food Empire Holdings Limited.
by Financial PR Pte Ltd
Mr Ngo Yit Sung, yitsung@financialpr.com.sg
Ms Yong Jing Wen, jingwen@financialpr.com.sg
Tel: +65 6438 2990 Fax: +65 6438 0064

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57464/

Parkson Announces the Annual Results for the Year Ended 31 December 2019

HONG KONG, Feb 25, 2020 - (ACN Newswire) - Parkson Retail Group Limited ("Parkson" or the "Company", with its subsidiaries collectively referred as the "Group", HKEx stock code: 3368.HK), the leading nationwide lifestyle concept retailer in China, today announces the Group's annual results for the year ended 31 December 2019 ("Year under Review").

In 2019, China has faced multiple fronts of downward pressure, which somewhat dampened the country's consumption sector as well. Amid risks, however, the retail market demonstrated remarkable resilience compared with other sectors. During the Year under Review, the Group has achieved stable performance, by continuing to diversify its retail formats, focus on expanding certain specific consumption sectors and enhance product offerings. The Group recorded total gross sales proceeds of RMB14,181.2 million inclusive of value-added tax, a decline of 6.7% compared to last year, which was mainly due to the closure of underperforming stores in 2019 and the decline in same store sales. Total operating revenues of the Group increased by RMB178.2 million or 3.7% to RMB 5,026.0 million, profit from operations increased by 179.3% year-on-year to RMB474.5 million. Same store sales decreased by 3.9% in 2019.

Differential Positioning Creates Synergies

Following a period of business transformation, Parkson is expanding its retail portfolio while flexibly applying various operating models and financial arrangements to strengthen the Group's position as a leading lifestyle retailer in China. In June 2019, the Group secured the usage right of a property above Bayi Guan Station of the Rail Transit Line 1 in Nanchang City, Jiangxi Province, China, with a total gross area of 42,900 square meters, and this new Nanchang Bayi Guan Store saw its grand opening on 16 January 2020. The new department store is located on the prosperous Zhongshan Road in the old city of Nanchang, above the intersection of two subway lines and is just across the road from Nanchang Zhongshan Road Store. The Zhongshan Road Store is a hub for high-end brands while the Bayi Guan Store focuses on young and fashion brands. The tactics of differential positioning along with close collaboration of the two stores have created synergies and attracted a wider customer group, allowing the Group more flexibility while leveraging on its diversified retail formats.

Strategic Business Expansion

In terms of the department store business, the Group's second department store in Datong, Shanxi Province, China is expected to open in the second quarter of 2020. It is expected that this retail space will be a "Complex of department stores and shopping centers", which will further diversify the product mix within the facility. It also fits into the Group's Differential Positioning tactics for "Multiple Stores in a City", which aim to serve more customers with different spending habits. In addition, preparation work for the Group's department store in Tongren city, Guizhou Province, China is well under way and the store is expected to welcome guests in the second quarter of 2020.

Strong Performance of Beauty Segment

In recent years, the Group has been actively exploring the beauty segment, and has recorded ideal performance. The Group also focuses on the innovation and exploration of business model in this field. "Parkson Beauty", the Group's beauty concept store, has been performing well and received positive response from customers. It has attracted various international beauty brands and created a brand-new beauty upgrading experience for consumers. Up to now, "Parkson Beauty" has set up three retail outlets in Changsha, Qingdao and Nanning, and has become a leading collection store of high-end beauty brands. In order to enhance the brand image and popularity of the Group's beauty segment, the Group has made a number of promotions actively. It is worth mentioning that, Malaysia's Lee Chong Wei, who is inducted into the Badminton Hall of Fame, was invited to "Parkson Beauty" as a "one-day manager" in its Changsha IFS store in November 2019. The event attracted a large number of customers and fans of Lee Chong Wei.

Fast Fashion Segment with Bright Prospects

In addition to the beauty segment, the fast fashion segment has become another new business direction of the Group. In 2019, Parkson has launched its self-owned fast fashion brand "evry-D" and set up sales counters in five retail stores within a short period. With its unique brand concept and business model, "evry-D" has attracted the attention of consumers and the industry. It is also a new trend of Parkson in business transformation and innovation. In view of the growing consumption power of the younger generation, the Group will continue to expand the scale of "evry-D" counters in 2020, so as to enhance its brand influence and enlarge its market share. Besides, the Group has also actively discussed with other brand operators to seek feasible cross-border cooperation, and is committed to promoting the long-term development of the Group's fashion sector through a variety of operation modes.

Parkson's management commented, "Whilst the macroeconomic environment is expected to be uncertain in the coming year, we remain optimistic about China's retail industry. Furthermore, our strategic business transformation has brought significant benefits to the Group through our practice in the past few years. To catch the rising opportunities, we will expand our business scale to cater to the fast pace of modern life and customers' needs for pleasant shopping experience. With a number of one-stop comprehensive retail premises, we are poised to take advantage of our product sales, logistics and data collection capabilities to create a comprehensive and relaxed shopping experience for customers."

"Parkson will continue to carry out its strategy of upgrading brands and product categories by diversifying retail formats and further exploring omni-channel marketing. It will also be devoted to developing its various business segments, including the beauty segment led by 'Parkson Beauty' and the fashion segment led by its own fast fashion brand 'evry-D'. The Group will actively strengthen the cooperation between its own brands and other brands, create more interactive effects, and constantly improve brand awareness and product quality. We believe that by virtue of the Group's diversified business strategy and its leading position in China's retail market, the Group is able to provide customers with the best quality services constantly, achieve outstanding performance amid challenging retail environment and drive the Group's long-term development."

About Parkson Retail Group Limited
Parkson Retail Group Limited ("Parkson") is a leading nationwide lifestyle retail operator in China. As of 31 December 2019, the Group operated and managed 38 Parkson stores (including concept stores "Parkson Beauty"), 1 Lion Mall, 2 Parkson Newcore City Malls, supermarkets, fashion and food & beverage outlets, in 27 major cities across China.

With over two decades of retail experience in China, Parkson understands market developments and consumer demand. The Group incorporates shopping, dining and entertainment elements, within a combination of offline and online channels to cater to young and middle-to upper-middle-income consumers.





Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

source http://www.acnnewswire.com/press-release/english/57460/

NECファシリティーズ、環境試験装置トップメーカーであるエスペック株式会社 豊田試験所のグローバル規格対応リニューアル工事を完工

TOKYO, Feb 25, 2020 - (JCN Newswire) - NECファシリティーズ株式会社(本社:東京都港区、代表取締役社長:松下 裕、以下「NECファシリティーズ」)はエスペック株式会社(本社:大阪市北区、代表取締役社長:石田 雅昭、以下「エスペック」)よりグローバル試験規格へ対応するリニューアル工事を受注。NECファシリティーズが保有する特殊環境空間の構築技術に基づく知見、ノウハウを生かした工事を実施し、このたび竣工しました。

近年、自動車の電動化、自動運転技術の実用化に向けた開発競争が激化しており、日本の車載機器メーカーは欧州自動車メーカーとの取り引きが増加しています。このようなグローバル化を背景に、各種部品の国際規格への対応が必須となる中、メーカー各社では人材不足が顕在化しており、高度かつ複雑、多種にわたるグローバルな試験規格に準拠した受託試験の需要が高まっています。

このような需要に対応するため、環境試験装置の世界トップメーカーであるエスペックは、車載部品品質のグローバル規格にワンストップ・ワンロケーションで対応する国内初の環境試験の受託試験所として、豊田試験所に新たな試験設備を導入し、試験所の稼働を継続しながらリニューアルしました。

本リニューアルにおいてNECファシリティーズは、仕様設定、予算計画、工事コスト削減、施工計画など、総合マネジメント力でエスペックを支援し、工事を完了しました。NECファシリティーズはNECのインハウス部門を原点としており、製造業の生産現場や特殊環境施設の構築に強みを持つことから、今回の特殊試験設備の設置における課題解決や試験作業環境の改善、安全性・作業効率の向上にも貢献しました。

本リニューアル工事における課題と対応、施工のポイントは以下の通りです。

- 特殊環境試験に適応した仕様の設定と施工実施
特殊な環境構築の技術とノウハウを生かし、100dB以上の騒音が発生する複合振動試験に対し、導入前と同等の騒音値を達成。近隣第一種住居地域規制値をクリア。

- 既存受託試験を継続しながらリニューアル工事を実施
受託試験オペレーションとの緊密な連携をはかりつつ、施工エリアの複数ブロック段階化施工とすることで、既存設備での受託試験を進めながらリニューアルを実現。

- 試験作業環境改善につながる諸施策を提案し施工
試験作業、物品運搬動線上の構造改善による可用性、安全性、作業効率の向上など。

- 納期遵守
試験エリアの改修、空調や分電盤の整備、壁面の美装化まで試験所の全面リニューアルを6か月と短期間で完了。

本工事では、NECファシリティーズのチーム力と総合マネジメント力を駆使したことで、エスペックから的確かつ迅速な対応力と提案力で期待を超える内容であると評価されました。また、エスペックの顧客である車載機器メーカーや実際に作業を行うエスペックの試験所員の皆さまからも好評を得ています。

NECファシリティーズは今後、強みを持つクリーンルームをはじめとした特殊環境空間などの構築技術を駆使し、電気電子・車載部品・医薬・食品などの製造業、データセンター、物流倉庫などの産業を支える人やモノに最適な空間を実現する事業、および建物構築事業を拡大していきます。

NECファシリティーズは、建設・施設管理・環境・不動産・保険の5つを事業ソリューションとして保有しており、これらを総合的、有機的に運用するTotal IFM (Integrated Facility Management)のシナジーにより、顧客事業の"場"の「探す」「建てる」「使う」「守る」を提供しています。今後も製造業を中心にデータセンター、物流倉庫向けに工場等のライフサイクルマネジメント(Life Cycle Management)を実践するサービスを提供し、顧客価値の最大化に邁進してまいります。

本リリースの詳細は下記をご参照ください。
https://www.necf.jp/information/20200225.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

WEC 2019-2020年 第5戦 ローン・スター・ル・マン 決勝:TOYOTA GAZOO Racing、2台共に表彰台フィニッシュでランキング首位を堅守

Toyota City, Japan, Feb 25, 2020 - (JCN Newswire) - 2月23日(日)、米国テキサス州オースティンに位置するサーキット・オブ・ジ・アメリカズ(COTA)で、2019-2020年シーズンFIA世界耐久選手権(WEC)第5戦ローン・スター・ル・マンの決勝が6時間レースとして行われ、TOYOTA GAZOO RacingのTS050 HYBRIDは、2台が揃って表彰台フィニッシュを果たしました。

TS050 HYBRID 7号車(マイク・コンウェイ、小林 可夢偉、ホセ・マリア・ロペス)
3位(トップと2周差)、187周、ピットストップ7回、グリッド2番手、最速ラップ : 1分51秒970

TS050 HYBRID 8号車(セバスチャン・ブエミ、中嶋 一貴、ブレンドン・ハートレー)
2位(トップと51.524秒差)、189周、ピットストップ7回、グリッド3番手、最速ラップ : 1分50秒589

セバスチャン・ブエミ、中嶋 一貴、ブレンドン・ハートレーのTS050 HYBRID 8号車はミス無くレースを戦い、優勝したレベリオン1号車から51.524秒差の2位でフィニッシュ。2位につけるドライバーズ選手権争いで、首位との差を縮めました。

マイク・コンウェイ、小林 可夢偉、ホセ・マリア・ロペスのTS050 HYBRID 7号車は、最大値に設定されたサクセス・ハンディキャップにより、ライバルと対等に争うのは厳しい状況でしたが、それでも着実に6時間レースを戦い抜き、3位表彰台を獲得。ドライバーズ選手権では5ポイントリードで首位の座を守っています。

また、TOYOTA GAZOO Racingが首位に立つチームランキングでは、2位のレベリオン・レーシングとの差が33ポイントに縮小しましたが、シーズン残り3戦でのタイトル獲得を目指します。

6時間の決勝レースは、雲に覆われた空と、強風の下で正午にスタートが切られました。最前列2番手グリッドの7号車はロペス、3番手グリッドの8号車はブエミがスタートを担当。サクセス・ハンディキャップの差が大きかったこの2台は1周目で順位が入れ替わり、8号車が2位へ浮上しました。

2位へとポジションを上げた8号車のブエミは、ポールポジションからスタートし首位を逃げるレベリオン1号車から離されないように懸命な走行を続けました。スタートから90分経過後、8号車は首位と30秒差の2位でブエミからハートレーへとドライバー交代。3位の7号車はさらに40秒後方でロペスからコンウェイへとステアリングを引き継ぎました。

8号車はピットでの素早い作業で首位との差を20秒まで詰めると、ハートレーの好走でこれを維持し、首位へのプレッシャーをかけ続けました。ここCOTAで過去に3勝の経験を持つハートレーは、給油ピットの後も素晴らしいラップタイムで周回を重ねました。

レースが折り返しを過ぎて間もなく、8号車はハートレーから中嶋へと、7号車はコンウェイから小林へとドライバーチェンジ。共にそれまでと同様のレース展開で首位を追いました。

大きなサクセス・ハンディキャップにより、首位との差を縮めるのは困難でしたが、8号車の中嶋はプッシュを続け、最小限のタイムロスで最後のスティントを担当するハートレーへと交代。この時点で1周遅れとなっていた7号車も小林からロペスへ最後のバトンを渡しました。

8号車のハートレーは2位でチェッカー。7号車のロペスが2周遅れの3位で続き、TOYOTA GAZOO Racingは2台共に表彰台フィニッシュという結果でシーズン第5戦を終えました。

2台のTOYOTA GAZOO Racingは、今大会終了後もそのまま米国に留まり、3月20日にフロリダでWEC第6戦として行われるセブリング1000マイルレースに挑みます。この第6戦は、全8戦で戦われているWEC 2019-2020年シーズン最後の欧州外でのレースとなります。

村田 久武 TOYOTA GAZOO Racing WECチーム代表
レベリオン・レーシングの皆様、優勝おめでとうございます。我々も全力を尽くし、与えられた条件下でTS050 HYBRIDの性能を最大限引き出せたと思いますが、勝利には少し足りませんでした。当地テキサスで応援頂いた全てのファンの皆様に感謝します。また本日の2位表彰台により依然として選手権ポイントをリードしています。来月に迫るセブリングレースが待ちきれません。目標はもちろん、表彰台の中央に返り咲くことです。

小林 可夢偉(7号車)
私自身は楽しむことのできたレースでした。チームはレースウィークの当初から素晴らしい仕事をしてくれて、ピットストップも速かったです。サクセス・ハンディキャップを考慮すれば、3位というのは最良の結果だと思います。我々は全力を尽くしましたが、勝利を争うチャンスがなかったのは残念です。とはいえ、優勝したレベリオンはミス無く素晴らしいレースを戦いました。彼らには祝福を送ります。

マイク・コンウェイ(7号車)
厳しいレースでした。自分の担当するスティントでも、競争力あるラップタイムで走るのは困難でした。スタートでホセが前を行く8号車からそれほど離されなかったので、僅かな望みは持っていましたが、その後、差は開いていくばかりでした。我々は選手権争いのために可能な限り上位でフィニッシュすべく努力を続けました。ランキング首位を守れたのが救いです。

ホセ・マリア・ロペス(7号車)
計算上、LMP1クラスで最も遅い車両でレースを戦うのが簡単ではないことは分かっていましたので、この週末は可能な限り多くのポイント獲得する事に集中しました。もちろんレースを戦う以上、いつも優勝を目指していますが、今日は3位が精一杯でした。しかし、レースでは幾つか明るいニュースもありました。TS050 HYBRIDは非常に快適で、何度か良いラップタイムも刻めたことでそのパフォーマンスにも満足していますし、タイトル争いでもまだ我々は首位を守っています。

中嶋 一貴(8号車)
我々にとってはタフなレースでした。首位を行くレベリオンから大きく離されることはありませんでしたが、彼らは勝てるだけの速さを持っていました。ミス無くレースを戦って勝利を挙げたレベリオンチームを祝福します。純粋な速さでは我々に勝つチャンスはなかったと思います。我々はチームとして最大のパフォーマンスを発揮することに集中し、この週末、チームはそれに応えて素晴らしい仕事をしてくれました。

セバスチャン・ブエミ(8号車)
我々は今日、最善を尽くしましたし、これ以上できることはなかったでしょう。優勝したレベリオンは本当に素晴らしい走りで、我々には彼らを破るだけのペースがありませんでした。チームメイトの7号車がさらに多くのサクセス・ハンディキャップを課されたことで彼らとのバトルもなく、淡々としたレースになりました。我々は自分たちのできる限りのレースをしましたが、やや不思議な気分です。

ブレンドン・ハートレー(8号車)
我がチームは、ドライバーがミスなくスティントをこなし、ピットストップも素早く良いレースを戦いました。何かが起こらなけらば逆転が難しいことは分かっていましたが、レベリオンは完璧に走り切りました。彼らはとても競争力が高く、明らかに我々よりも良いペースで走っていました。決勝レース中、TS050 HYBRIDは快調で、他クラスの車両をかわしながらの走行は非常に楽しかったのですが、ライバルとの接近戦ができなかったのが少し残念です。

本リリースの詳細は下記URLをご参照ください。
https://global.toyota/jp/newsroom/toyota/31741772.html

概要:トヨタ自動車株式会社

詳細は http://toyota.jp/ をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

NECソリューションイノベータ、再雇用制度の対象者を拡大

TOKYO, Feb 25, 2020 - (JCN Newswire) - NECソリューションイノベータは、より多くの当社退職者に対して、再雇用の機会を提供するため、再雇用制度を見直し、3月1日より対象者を拡大します。これにより、当社の事業について知見を有し、退職後に多様な経験を培った退職者の再雇用をすることで、新たな価値の創出と当社の事業のさらなる活性化につなげます。

背景
人口減少・少子高齢化に向かう企業を取り巻く環境にあって、社会に対して新たな価値を提供し続け、企業としての持続可能性を高めていくためには、そうした社会的価値の提供に寄与できる人材を確保し続けることが重要です。

当社では、人材の確保をより促進するために、現在、経験者採用を拡大しています。その一環として、当社の事業について知見を有する人材の応募・確保の促進に向け、退職者の再雇用について条件を緩和し、今後、積極的な採用を進めていきます。

概要
再雇用の条件を緩和し、より多くの当社退職者に対して、再雇用の機会を提供していきます。なお、再雇用にあたっては、その時点で当社が必要とする職種において、経験者採用に準じた方法で選考を行います。

<改定内容>
- 再雇用においては、これまで配偶者の転勤、育児・介護または学位の取得を事由とする退職のみを対象としていたが、退職事由を問わず、当社退職者を対象とする。但し、解雇または同等の事由の場合は除く。
- 再雇用条件の「勤続3年以上」を廃止する。

NECソリューションイノベータは、多様な人材が活躍できる環境を整え、社会に価値を提供し続けることで、持続可能な社会の実現に貢献していきます。

NECグループは、安全・安心・効率・公平という社会価値を創造する「社会ソリューション事業」をグローバルに推進しています。当社は、先進ICTや知見を融合し、人々がより明るく豊かに生きる、効率的で洗練された社会を実現していきます。

本リリースの詳細は下記をご参照ください。
https://www.nec-solutioninnovators.co.jp/press/20200225/index.html

概要:日本電気株式会社(NEC)

詳細は www.nec.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

エーザイと富士薬品、痛風・高尿酸血症治療剤ドチヌラドについて中国における開発・販売に関するライセンス契約を締結

TOKYO, Feb 25, 2020 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤晴夫、以下 エーザイ)と株式会社富士薬品(本社:埼玉県、代表取締役社長:高柳昌幸、以下 富士薬品)は、このたび、富士薬品が創出した痛風・高尿酸血症治療剤ドチヌラド(一般名)について、中国における開発・販売に関するライセンス契約を締結しましたのでお知らせします。

本契約により、エーザイは富士薬品より、中国におけるドチヌラドに関する独占的開発権・販売権を獲得します。製剤は富士薬品が生産し、エーザイに供給します。エーザイは富士薬品に対して契約一時金と開発ならびに販売マイルストンを支払うとともに、中国における新薬承認申請を担います。

高尿酸血症は、中国において、糖尿病に次いで2番目に多い代謝性疾患であり、痛風をはじめ、泌尿器系、内分泌系、代謝系、脳心血管系などにおける様々な疾患に関連していることが知られています。中国における現在の高尿酸血症患者数は約1.9億人、痛風患者数については約1,600万人と推定されています。これらの患者様の数は、社会経済の発展に伴う生活習慣や食嗜好の変化等に伴い、今後もさらに増加することが予想されています。

ドチヌラドは、富士薬品が創出した新規の痛風・高尿酸血症治療剤です。腎臓での尿酸再吸収に関与するトランスポーター(URAT1)を選択的に阻害することにより、尿酸の再吸収を抑制し、血中尿酸値を低下させます。

本契約により、エーザイは、中国において本剤の開発を進め、商業化後は、中国事業において培ったナレッジやネットワークを活用し、アンメット・メディカル・ニーズを有する患者様への貢献をめざします。富士薬品は、ドチヌラドの世界展開への第一歩として、エーザイの中国事業の基盤活用により、本剤の中国における価値最大化を期待しています。

両社は、本剤の開発・商業化により、中国における痛風・高尿酸血症に対する新たな治療選択肢を提供し、患者様のQOL(クオリティ・オブ・ライフ)の向上に貢献してまいります。

本リリースの詳細は下記をご参照ください。
https://www.eisai.co.jp/news/2020/news202010.html

概要:エーザイ株式会社

詳細は www.eisai.co.jp をご覧ください。



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

Tomini Shipping Approved and Registered for Listing on the NOTC

DUBAI, UAE, Feb 25, 2020 - (JCN Newswire) - Tomini Shipping, a world-class ship owner and operator in the dry bulk sector with operations in the UAE and India, has registered on the Norwegian Over the Counter market (the "NOTC").

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/6965/52689_b021ecde54cf3a4a_001full.jpg

"Our ambition is to meet global transportation needs through expanding our fleet with the latest eco-friendly, technologically advanced vessels, which are able to deliver exceptional service to our global client network. With our experienced management team and highly motivated employees, Tomini Shipping is ready to lead the way," says Imtiaz Shaikh, Chairman.

"The listing of Tomini on the NOTC is an exciting milestone. We believe that the broader exposure afforded by the NOTC will raise our visibility within the investment community and generate exposure of Tomini Shipping among institutional investors," says Nitin Mehta, CEO.

Tomini Shipping will continue to look for new investment and acquisition opportunities that fit the Company's existing business platform. The company has 12 Ultramax dry bulk carriers on the water, in addition to three Kamsarmax newbuilding orders with Taizhou Koaun in China, with delivery in 2020 and 2021.

NOTC is an unregulated marketplace owned and managed by the Oslo Stock Exchange.

About Tomini Shipping

Tomini Shipping is a world-class ship owner and operator in the dry bulk segment and majority-owned by Imtiaz Mohammad Shaikh, which for more than 65 years has been involved in every aspect of the shipping market including ownership, technical management and manning. Commercial management of Tomini's fleet of modern vessels is handled through Alpina Chartering in Denmark, for the last 40 years, who are also partners.

Tomini Shipping has received multiple industry awards, most recently being recognized by the Maritime Standard. The company's strategy focuses on being the most trusted partner in maritime services to their clients guided by their values and commitment to safety, corporate responsibility and sustainability. Further information can be found at https://tominishipping.com

For more information contact:
Sinead Brady
Head of Corporate Communications
+971 4 306 2000

Related Images:
Tomini Shipping 1
Tomini-shipping-1.jpg,
Imtiaz Shaikh, Chairman & Nitin Mehta, CEO
https://www.newsfilecorp.com/redirect/Xm7JuAbv

Tomini Shipping 1.2
tomini-shipping-1-2.jpg
Tomini Shipping Leadership Team
https://www.newsfilecorp.com/redirect/DPzEh7jk

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/52689



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02

NanoViricides has filed Quarterly Report for period ending December 31, 2019; Sufficient Cash, HerpeCide(TM) Drug Candidate IND Application Development in Progress

SHELTON, CT / ACCESSWIRE, Feb 24, 2020 - (JCN Newswire) - NanoViricides, Inc. (NYSE American: NNVC), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, has filed its quarterly report for its second quarter of financial year 2020 in a timely manner with the Securities and Exchange Commission. This press release should be read in conjunction with the Form 10-Q filed on February 14, 2020. The submission can be downloaded from the SEC website at: https://www.sec.gov/Archives/edgar/data/1379006/000110465920021930/tm205411-1_10q.htm.

The Company reported that it had approximately $1.0 Million (M) of current assets (cash, cash equivalents, and prepaid expenses), and current cash liabilities of approximately $1.4M excluding a recent mortgage (described below), as of December 31, 2019, the end of the reporting period. The net cash used in operating activities during the six months period was approximately $2.56M. The Company's expenditures were in line with budget estimates. Shareholder equity stood at approximately $7.72M for the quarter (unaudited figures), primarily due to the asset value of its cGMP-capable manufacturing facility, R&D labs, and equipment, that it owns fully except for a $2 Million secured debt provision. The Company had no revenues. The Company has no long term debt.

The Company drew down $1.1M from a $2M non-convertible loan commitment secured by a mortgage on the Company's facility provided by the Company's founder and President, Anil R. Diwan, PhD. The mortgage is payable in full on March 31, 2021, with no payments due until then. Interest is payable only on amounts drawn by the Company.

In subsequent events, the Company has previously reported that it has raised approximately $8.625M in gross proceeds in an underwritten public offering, pursuant to an effective Form S-1 registration statement, comprising the sale of 2.5 million shares plus 375,000 shares of an underwriters over-allotment option at a price of $3 per share, with no warrants issued in the transaction. Aegis Capital Corp. acted as sole bookrunner for the offering. The net proceeds to the Company after underwriter's commission and agreed upon customary fees and expenses were approximately $7.78 million, before deducting the Company's legal and accounting expenses related to the Offering.

With these cash inflows, the Company believes it has sufficient funding for its planned expenditures for the ensuing year, based on estimated budgets including costs of certain clinical trials.

In subsequent events, the Company previously reported that it is working on developing a therapeutic drug for the treatment of the novel coronavirus 2019-nCoV, aka COVID-19. In 2014, the Company had engaged in drug discovery efforts against MERS coronavirus. The Company has reported that it has already found broad-spectrum virus-binding ligands that are expected to attack the virus at the same points that the virus uses to bind to its cognate cellular receptor, namely ACE-2 (angiotensin converting enzyme type 2), using molecular modeling based on known SARS-CoV and ACE2 interactions. COVID-19 shares significant similarity with, and uses the same cellular receptor as, SARS-CoV. The Company intends to perform initial testing of these drug candidates for safety and effectiveness in cell culture studies in its own BSL-2 virology laboratory at its Shelton campus, using low-threat coronavirus strains that have been normally circulating in human population.

The Company is working on developing necessary collaborations to take the program further should an effective drug candidate be identified. However, there can be no assurance that the Company will be successful in entering into such collaborations or that such collaborations will lead to an effective drug candidate. The Company does not currently have a license for the coronavirus field from TheraCour Pharma, Inc. ("TheraCour"), the licensor of the Company's pharmaceutical candidates and a significant shareholder. Customarily, the Company enters into licensing agreements with TheraCour after a potential drug candidate is demonstrated to be likely effective against the virus. TheraCour has not previously denied any licenses sought by the Company.

The Company has experience developing broad-spectrum cellular receptor mimetics as virus-binding ligands for creating nanoviricide drugs. The Company has demonstrated this capability notably in its HerpeCide(TM) program, wherein nanoviricides based on the same antiviral ligand were found to be effective against at least three different kinds of herpesviruses, namely herpes simplex-1 (HSV-1), herpes simplex-2 (HSV-2), and, surprisingly, the non-simplex varicella zoster virus (VZV).

It is well recognized that development of vaccines takes a long time, and that vaccines can often be ineffective against viruses due to viral mutations that lead to emergence of resistant strains. It is also well recognized and well documented that monoclonal antibodies as antiviral drugs are very difficult to develop and often lead to emergence of resistant viral strains due to viral mutations.

In contrast, the Company believes that, its nanoviricide biomimetic technology platform has the potential to develop broad-spectrum antiviral drugs that viruses may not be able to escape due to mutations.

The Company continues to advance its first drug candidate, namely NV-HHV-101 skin cream, for the treatment of shingles rash as its first indication, towards human clinical trials. All of the planned IND-enabling Safety/Toxicology studies as well as other required non-clinical studies have been completed, and draft reports of various studies are being circulated between collaborating parties, as of the filing date. The Company anticipates receiving final cGLP reports for inclusion in our IND filing once the quality assurance processes are completed.

The Company has undertaken cGMP manufacture of the drug product, namely, NV-HHV-101 skin cream, indicated for the topical treatment of shingles rash, for supplying anticipated Phase I human clinical trials at its own facility. The Company has industry-leading internal expertise in the cGMP manufacture of complex nanomedicines drugs, right from simple starting materials to formulated drug products.

In a human skin patch organ culture model ex vivo, the Company has previously demonstrated the effectiveness and safety of topical NV-HHV-101 against VZV, the cause of shingles and chickenpox. These studies were conducted by Professor Jennifer Moffat at the Upstate Medical Center, SUNY Syracuse, NY. Professor Moffat has developed this model for pre-clinical evaluation of therapeutics against VZV, and is a well known expert in the field.

It is anticipated that the high effectiveness of our clinical drug candidate observed in this human skin model should be predictive of effectiveness in human clinical trials for topical dermal treatment of shingles.

Following shingles drug development, the Company anticipates developing drugs for HSV-1 cold sores and HSV-2 genital ulcers treatments using NV-HHV-101. The total market for our HerpeCide(TM) program drugs is estimated at several tens of billions of dollars because neither cures nor very effective treatments are available. The Company also has drug candidates in development at different pre-clinical stages in its Influenza and HIV drug programs. In addition, the Company has drug candidates against Dengue viruses, and was developing drugs against Ebola/Marburg viruses among others. The Company anticipates re-engaging these programs upon appropriate financing becoming available. Thus the Company has a rich and expanding pipeline of highly effective and safe drug candidates against a number of viral diseases.

NanoViricides is pioneering a unique platform for developing anti-viral drugs based on the "bind-encapsulate-destroy" principles. Viruses would not be able to escape a properly designed nanoviricide(R) drug by mutations because in doing so they would lose the ability to bind their cognate cellular receptor(s) and thus fail to infect productively, becoming incompetent.

There is a significant unmet medical need for the topical treatment of shingles rash. An effective therapy for shingles has been estimated to have a market size into several billions of dollars, if it reduces PHN incidence. An effective therapy for shingles rash reduction alone is estimated to have a market size of several hundred million dollars to low billion dollars. These market size estimates have taken into account the potential impact of the new Shingrix(R) GSK vaccine, assuming scaling up of their production in the 2024 time-frame, and the impact of the existing Zostavax(R) vaccine. Of note, the Shingrix vaccine has been found to cause significant, debilitating, side effects in as many as 15%-20% of the persons receiving it. Given that shingles is not a life-threatening disease (except under certain conditions), the uptake of such a vaccine with high incidence of adverse effects may be limited. Shingrix is not yet widely available.

The Company develops its class of drugs, that we call nanoviricides(R), using a platform technology. This approach enables rapid development of new drugs against a number of different viruses. A nanoviricide is a "biomimetic" - it is designed to "look like" the cell surface to the virus. The nanoviricide(R) technology enables direct attacks at multiple points on a virus particle. It is believed that such attacks would lead to the virus particle becoming ineffective at infecting cells. Antibodies in contrast attack a virus particle at only a maximum of two attachment points per antibody. In addition, the nanoviricide technology also simultaneously enables attacking the rapid intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The nanoviricide technology is the only technology in the world, to the best of our knowledge, that is capable of both (a) attacking extracellular virus, thereby breaking the reinfection cycle, and simultaneously (b) disrupting intracellular production of the virus, thereby enabling complete control of a virus infection.

About NanoViricides

NanoViricides, Inc. (www.nanoviricides.com) is a development stage company that is creating special purpose nanomaterials for antiviral therapy. The Company's novel nanoviricide(R) class of drug candidates are designed to specifically attack enveloped virus particles and to dismantle them. Our lead drug candidate is NV-HHV-101 with its first indication as dermal topical cream for the treatment of shingles rash. The Company is also developing drugs against a number of viral diseases including oral and genital Herpes, viral diseases of the eye including EKC and herpes keratitis, H1N1 swine flu, H5N1 bird flu, seasonal Influenza, HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus, among others. The Company's technology is based on broad, exclusive, sub-licensable, field licenses to drugs developed in these areas from TheraCour Pharma, Inc.

Contact:
NanoViricides, Inc.
info@nanoviricides.com

Public Relations Contact:
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by NanoViricides, Inc. are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Although it is not possible to predict or identify all such factors, they may include the following: demonstration and proof of principle in preclinical trials that a nanoviricide is safe and effective; successful development of our product candidates; our ability to seek and obtain regulatory approvals, including with respect to the indications we are seeking; the successful commercialization of our product candidates; and market acceptance of our products. FDA refers to US Food and Drug Administration. IND application refers to "Investigational New Drug" application. CMC refers to "Chemistry, Manufacture, and Controls".

SOURCE: NanoViricides, Inc.



Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com Via JCN Newswire https://ift.tt/2pbRN02